These results indicate that CHI3L1 is involved in the development and progression of aggressive lymphoma, suggesting that it may be a promising biomarker and therapeutic target, which could help to elucidate the molecular mechanisms of aggressive lymphoma and promote the development of novel diagnostic tools and therapeutic strategies. The gene discussed is CHI3L1; the disease is lymphoma.